Please sign in to follow a disease.
Can eye movements reveal the Brain's visual priorities?
NCT ID NCT07756853
First seen Aug 11, 2026 · Last updated Sep 21, 2026 · Updated 28 times
Summary
This observational study aims to understand how healthy adults process and respond to visual images, particularly socially relevant ones like faces. Researchers will track eye movements and attention as participants view images on a screen. The study involves healthy volunteers aged 18 and older with normal vision, who will attend several clinic visits over a few months. By measuring eye movement patterns, the study seeks to uncover how certain visual features automatically capture attention.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- This research could deepen understanding of how the brain prioritizes visual information, potentially informing future studies on visual perception and attention disorders.
- What could go wrong
- As an observational study with a small number of participants, findings may not apply broadly. The results are exploratory and may not lead to immediate practical applications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2031
An estimate. End dates often move.
- Lead sponsor
-
A government research agency
The lead sponsor is the US National Institutes of Health.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Healthy volunteer adults, over age 18, of either sex
- Ages
-
18 to 100 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
* INCLUSION CRITERIA: In order to be eligible to participate in this study, an individual must meet all of the following criteria: * Stated willingness to comply with all study procedures and actively pay attention to visual stimuli and respond as appropriate. * Participant has visual acuity of 20/25 or better in both eyes. * Participant must be 18 years old or older. * Participant must understand and be willing to sign a written informed consent document. EXCLUSION CRITERIA: An individual who meets any of the following criteria will be excluded from participation in this study: * Participant has an ocular, visual, or oculomotor problem that in the opinion of the Principal Investigator (PI) and/or clinical associate investigator would interfere with the participant s normal eye movements, visual perception, or required tasks. * Participant has a history of eye patching (amblyopia or lazy eye). * Participant has a non-ocular condition (e.g., neuropsychological conditions) that in the opinion of the PI and/or clinical associate investigator would interfere with the participant s normal eye movements or visual perception.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy volunteer are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental brain drug TAK-935 put to the test in healthy volunteers
- Tracing a Low-THC cannabis extract through the human body
- Can a new injection SGB-9768 pass its first safety test?
- Can a new PET tracer reveal the Body's hidden stress?
- Zapping the brain to shift Decision-Making in depression and aging
- Can a new formula make omega-3 and vitamin D3 supplements work better?